The biologic drug dupilumab lowers the rate of severe asthma attacks and improves lung function and asthma control for children ages 6 to 11, researchers reported on December 9, 2021 in… read more.
Findings also reveal decline in smoking led to decrease in another type of lung cancer. An international team of scientists, led by Nanyang Technological University, Singapore (NTU Singapore),… read more.
First microfluidic organ-on-a-chip model of the disease could help bring much needed drugs, and personalized medicine approaches to patients. The inherited progressive disorder cystic fibrosis (CF) causes severe… read more.
The haze that blurs a blue sky or a beautiful skyline is caused by tiny particles called PM2.5. PM2.5 describes particulate matter, often made from pollution, less than 2.5… read more.
Head and neck cancer survivors with long smoking histories had a 2.5-fold greater risk of developing lung cancer than those without prior head and neck cancer, according to… read more.
Medtronic plc has announced new clinical data from the NAVABLATE study, which highlights the much anticipated safety and performance results on microwave ablation used bronchoscopically with the Emprint… read more.
Addition of baricitinib to standard of care (including dexamethasone and remdesivir) was associated with reduced mortality among hospitalized adults with COVID-19, researchers reported on Sept. 1, 2021 in… read more.
Following the news of the acquisition of Vectura by Philip Morris International (PMI), we would like to clarify GSK’s position regarding Ellipta inhalers and their association with Vectura.
Moderately ill patients hospitalized with COVID-19 have achieved a better rate of respiratory organ support-free days and survival if treated with therapeutic-dose anticoagulation, researchers reported on August 20,2021… read more.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the FDA has approved Uptravi (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension… read more.
Asthma afflicts more than 300 million people worldwide. The most severe manifestation, known as non-Th2, or non-atopic childhood asthma, represents the majority of the cases, greater than 85%,… read more.
Article written by Bruce Sylvester. Researchers report that, when compared with dual inhaler therapy for moderate to severe asthma, triple therapy for children aged 6 to 18 years… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
